ArticleFrontiers in oncology2021

Sorafenib Versus Apatinib Both Combined Transarterial Chemoembolization for Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis: A Comparative Retrospective Study.

Yanyan Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.